Src-like adaptor protein 2 (SLAP2) binds to and inhibits FLT3 signaling

Fms-like tyrosine kinase (FLT3) is a frequently mutated oncogene in acute myeloid leukemia (AML). FLT3 inhibitors display promising results in a clinical setting, but patients relapse after short-term treatment due to the development of resistant disease. Therefore, a better understanding of FLT3 do...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Oncotarget
Asıl Yazarlar: Moharram, Sausan A., Chougule, Rohit A., Su, Xianwei, Li, Tianfeng, Sun, Jianmin, Zhao, Hui, Rönnstrand, Lars, Kazi, Julhash U.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Impact Journals LLC 2016
Konular:
Research Paper
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5295388/
https://ncbi.nlm.nih.gov/pubmed/27458164
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.10760
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller